Janus Henderson Group
PACB icon

Janus Henderson Group’s Pacific Biosciences PACB Stock Holding History

Janus Henderson Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-109,941
Closed -$125K – 2484
2025
Q1 		$125K Hold
109,941
– – ﹤0.01% 2441
2024
Q4 		$200K Hold
109,941
– – ﹤0.01% 2428
2024
Q3 		$186K Hold
109,941
– – ﹤0.01% 2449
2024
Q2 		$150K Sell
109,941
-1,383
-1% -$2.79K ﹤0.01% 2459
2024
Q1 		$417K Buy
111,324
+48
+0% +$281 ﹤0.01% 2092
2023
Q4 		$1.09M Sell
111,276
-120
-0.1% -$981 ﹤0.01% 1580
2023
Q3 		$930K Buy
111,396
+135
+0.1% +$1.54K ﹤0.01% 1590
2023
Q2 		$1.48M Buy
111,261
+10,383
+10% +$126K ﹤0.01% 1404
2023
Q1 		$1.17M Buy
100,878
+63,472
+170% +$631K ﹤0.01% 1542
2022
Q4 		$306K Sell
37,406
-37,410
-50% -$322K ﹤0.01% 1969
2022
Q3 		$436K Buy
74,816
+37,386
+100% +$215K ﹤0.01% 2024
2022
Q2 		$166K Sell
37,430
-14
-0% -$85 ﹤0.01% 2367
2022
Q1 		$340K Buy
37,444
+13
+0% +$150 ﹤0.01% 2143
2021
Q4 		$765K Buy
37,431
+18,898
+102% +$456K ﹤0.01% 1633
2021
Q3 		$474K Buy
+18,533
New +$549K ﹤0.01% 1642

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group's PACB Position: Q2 2025 in Review

Janus Henderson Group sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 109,941 shares — an estimated $125K sold.

Janus Henderson Group first reported a position in PACB in Q3 2021 and held it in 15 quarters. The position peaked at $1.48M in Q2 2023. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • Janus Henderson Group reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • Janus Henderson Group sold 109,941 Pacific Biosciences shares in Q2 2025, an estimated $125K.
  • Janus Henderson Group first reported a position in Pacific Biosciences in Q3 2021 and held it in 15 quarters.
  • Janus Henderson Group's Pacific Biosciences position peaked at $1.48M in Q2 2023.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Janus Henderson Group's 13F filing for Q2 2025, filed 14 Aug 2025.